Epidural Analgesia Use in Pancreatic Resections
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Pancreatic Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/21/2018 |
| Start Date: | June 7, 2016 |
| End Date: | September 6, 2019 |
The rationale for this study is to investigate the benefits of epidural analgesia in
pancreatic resections in a prospective, single blind, randomized control trial. This study
will evaluate both short and long-term outcomes related to epidural analgesia, providing a
longitudinal and comprehensive perspective to the advantages and disadvantages of this
technique. The investigators hypothesize that the use of epidural analgesia reduces a
patient's consumption of morphine or morphine-equivalent in the post-operative period
following pancreatic resections.
pancreatic resections in a prospective, single blind, randomized control trial. This study
will evaluate both short and long-term outcomes related to epidural analgesia, providing a
longitudinal and comprehensive perspective to the advantages and disadvantages of this
technique. The investigators hypothesize that the use of epidural analgesia reduces a
patient's consumption of morphine or morphine-equivalent in the post-operative period
following pancreatic resections.
Inclusion Criteria:
- Undergoing pancreatic resection.
- Age ≥18 years old.
- Able to understand and sign an Institutional Review Board (IRB)-approved informed
consent form.
Exclusion Criteria:
- Indication for operative intervention being chronic pancreatitis.
- Currently on warfarin with an INR≥1.4 or clopidogrel that cannot be discontinued 7
days prior to surgery;
- Most recent INR prior to surgery >1.4
- Most recent platelet count prior to surgery <70,000/mcl
- Chronic opioid use as defined by use of more than 20mg oxycodone, or equivalent,
daily.
- History of pre-existing neuropathic pain conditions.
- Not giving consent for study participation.
- Known medical history of significant psychiatric or cognitive impairment
- History of HIV, Hepatitis B, and/or Hepatitis C
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Michael Bottros, M.D.
Phone: 314-747-5139
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Click here to add this to my saved trials
